
Sera Prognostics, Inc.
Sera Prognostics, Inc. (SERA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SERA · as of Jun 9, 2026
Key Statistics
Explore Sera Prognostics, Inc. Data
sera stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The SERA analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $5.50, representing +161.90% upside from the current price of $2.10.
Competitors & Peers
sera competitorsStock Performance
Full HistoryAbout Sera Prognostics, Inc.
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the…
what is sera prognostics, inc. · sera stock overview · sera prognostics, inc. company profile · who is sera prognostics, inc. ceo · sera NASDAQ · sera prognostics, inc. headquarters · sera prognostics, inc. business segments
About Stock Overview & Key Data
Sera Prognostics, Inc. (SERA) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jul 15, 2021. As of the latest trading session, SERA stock price is $2.10, with a market capitalization of $80.2M. The stock has returned +40.00% over the past 12 months and -28.81% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Sera Prognostics, Inc. stock is Buy, with an average 12-month price target of $5.50. In fiscal year 2025, Sera Prognostics, Inc. reported revenue of $81000.00 and net income of -$31.9M. For detailed data — including Sera Prognostics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Sera Prognostics, Inc. (SERA) stock price is $2.10. The stock is traded on NASDAQ under the ticker symbol SERA. The 52-week range is $1.41 – $4.09.